What does it mean to be made vulnerable in the era of Covid-19?

Article indépendant

AHMAD, Ayesha | CHUNG, Ryoa | ECKENWILER, Lisa | GANGULI, Agomani Mitra | HUNT, Matthew | RICHARDS, Rebecca | SAGHAI, Yashar | SCHWARTZ, Lisa | SCULLY, Jackie Leach | WILD, Verina

We read with interest the Editorial about redefining vulnerability in the era of coronavirus disease 2019 (COVID-19). The Editors recognise underserved and marginalised populations enduring the COVID-19 pandemic, and that the category of vulnerable individuals or groups is not fixed but evolves in response to policies that might create or reinforce vulnerability. When we ask what being vulnerable means, are we also creating the spaces needed to question what it means to be made vulnerable? [1er paragraphe]

http://dx.doi.org/10.1016/S0140-6736(20)30979-X

Voir la revue «The Lancet, 395»

Autres numéros de la revue «The Lancet»

Consulter en ligne

Suggestions

Du même auteur

What does it mean to be made vulnerable in th...

Article indépendant | AHMAD, Ayesha | The Lancet | n°10235 | vol.395

We read with interest the Editorial about redefining vulnerability in the era of coronavirus disease 2019 (COVID-19). The Editors recognise underserved and marginalised populations enduring the COVID-19 pandemic, and that the cate...

Aid when 'there is nothing left to offer' : e...

Article indépendant | SCHWARTZ, Lisa | PLOS global public health | n°2 | vol.3

Access to palliative care, and more specifically the alleviation of avoidable physical and psychosocial suffering is increasingly recognized as a necessary component of humanitarian response. Palliative approaches to care can meet...

Conscientious objection and institutional obj...

Article indépendant | KERRIDGE, Ian | Journal of law and medicine | n°4 | vol.30

This column examines conscientious objection and institutional objection in Australian voluntary assistance in dying. It reviews the current legislative regimes and then examines these practices from an ethical perspective, and ra...

De la même série

Defining and conceptualising the commercial d...

Article indépendant | GILMORE, Anna B. | The Lancet | n°10383 | vol.401

Although commercial entities can contribute positively to health and society there is growing evidence that the products and practices of some commercial actors—notably the largest transnational corporations—are respon...

Redefining vulnerability in the era of Covid-...

Article indépendant | The Lancet | n°10230 | vol.395

What does it mean to be vulnerable? Vulnerable groups of people are those that are disproportionally exposed to risk, but who is included in these groups can change dynamically. A person not considered vulnerable at the outset of ...

What does it mean to be made vulnerable in th...

Article indépendant | AHMAD, Ayesha | The Lancet | n°10235 | vol.395

We read with interest the Editorial about redefining vulnerability in the era of coronavirus disease 2019 (COVID-19). The Editors recognise underserved and marginalised populations enduring the COVID-19 pandemic, and that the cate...

Felicia Marie Knaul : advocate for better pai...

Article indépendant | DAVIES, Rachael | The Lancet | n°10128 | vol.391

The time before her father died of stomach cancer in 1984 had a lasting impact on Felicia Knaul. “Each day brought new and ever-more challenging horrors—bone metastases popping up throughout his body…lungs filli...

Early palliative care for patients with advan...

Article indépendant | ZIMMERMANN, Camilla | The Lancet | n°9930 | vol.383

Background: Patients with advanced cancer have reduced quality of life, which tends to worsen towards the end of life. We assessed the effect of early palliative care in patients with advanced cancer on several aspects of quality ...

Chargement des enrichissements...